BridgeBio Pharma to Host Virtual R&D Day on October 12, 2021

/PRNewswire/ -- BridgeBio Pharma, Inc. (Nasdaq: BBIO), a commercial-stage biopharmaceutical company that focuses on genetic diseases and cancers, today...

Related Keywords

,Charles Homcy ,Bridgebio Cardiorenal ,Katherine Yau ,Eli Wallace ,Mary Scott Roberts ,Bridgebio Pharma ,Richard Scheller ,Neil Kumar ,Jonathan Fox ,Suma Sinha ,Eric David ,Linkedin ,Bridgebio Pharma Inc ,Twitter ,Bio Pharma Inc ,Drug Administration ,Nasdaq ,Bio Pharma ,Grace Rauh ,Cameron Turtle ,Bridgebio Gene Therapy ,Bridgebio Oncology ,Bio Media Contact ,Bio Investor Contact ,Bridgebio ,Health Care Amp Hospitals ,Pharmaceuticals ,Medical Pharmaceuticals ,Biotechnology ,